Curis Inc (CRIS)
15.85
-0.47
(-2.88%)
USD |
NASDAQ |
May 10, 16:00
15.85
0.00 (0.00%)
After-Hours: 19:39
Curis Price to Book Value: 4.749 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.890 |
| May 08, 2024 | 4.899 |
| May 07, 2024 | 4.854 |
| May 06, 2024 | 4.845 |
| May 03, 2024 | 4.902 |
| May 02, 2024 | 4.947 |
| May 01, 2024 | 4.791 |
| April 30, 2024 | 4.600 |
| April 29, 2024 | 4.408 |
| April 26, 2024 | 4.336 |
| April 25, 2024 | 4.351 |
| April 24, 2024 | 4.426 |
| April 23, 2024 | 4.498 |
| April 22, 2024 | 4.450 |
| April 19, 2024 | 4.288 |
| April 18, 2024 | 4.561 |
| April 17, 2024 | 4.779 |
| April 16, 2024 | 4.576 |
| April 15, 2024 | 4.363 |
| April 12, 2024 | 4.579 |
| April 11, 2024 | 4.764 |
| April 10, 2024 | 4.579 |
| April 09, 2024 | 4.668 |
| April 08, 2024 | 4.944 |
| April 05, 2024 | 5.034 |
| Date | Value |
|---|---|
| April 04, 2024 | 4.797 |
| April 03, 2024 | 4.015 |
| April 02, 2024 | 3.692 |
| April 01, 2024 | 3.800 |
| March 28, 2024 | 3.257 |
| March 27, 2024 | 3.257 |
| March 26, 2024 | 3.024 |
| March 25, 2024 | 3.245 |
| March 22, 2024 | 3.236 |
| March 21, 2024 | 3.245 |
| March 20, 2024 | 3.095 |
| March 19, 2024 | 3.062 |
| March 18, 2024 | 3.041 |
| March 15, 2024 | 3.086 |
| March 14, 2024 | 3.053 |
| March 13, 2024 | 3.068 |
| March 12, 2024 | 3.002 |
| March 11, 2024 | 3.101 |
| March 08, 2024 | 3.146 |
| March 07, 2024 | 2.990 |
| March 06, 2024 | 2.925 |
| March 05, 2024 | 3.086 |
| March 04, 2024 | 2.908 |
| March 01, 2024 | 3.018 |
| February 29, 2024 | 3.053 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7727
Minimum
Oct 25 2023
12.22
Maximum
May 12 2021
3.576
Average
2.845
Median
Nov 30 2023
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.108 |
| Perspective Therapeutics Inc | 13.66 |
| Protalix BioTherapeutics Inc | 2.416 |
| Electromed Inc | 3.658 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 8.367 |
| Price | 15.85 |
| Earnings Yield | -56.53% |
| Market Cap | 93.42M |